{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:34:51Z","timestamp":1785803691458,"version":"3.56.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Deficiency of adenosine deaminase-2 (DADA2) is a monogenic disorder closely resembling PAN and can present to physicians across various specialties. Through this case series, we aimed to study and describe the clinical spectrum of and outcomes for Indian children with DADA2.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The de-identified data from all participating centres were entered in an Excel spreadsheet, and the coordinating centre (All India Institute of Medical Sciences, New Delhi) screened the data for accuracy and completeness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We enrolled 16 children (11 females) in the study; the mean (s.d.) age at the time of onset of symptoms for males and females was 46.2 (47) and 73.6 (50.4) months, respectively. The most common clinical features in this cohort were fever and rash in 80% of patients. More than half of the children, n (%) [8, (53%)] had a CNS stroke. The other clinical features were hypertension [5(33%)], anaemia [3 (20%)] and arthralgia\/arthritis in 4 (26%). These children were managed with various immunomodulators: steroids [13, (86%)], anti-TNF agents [12, (80%)], CYC [2 (13%)] and MMF [3 (20%)]. The median [interquartile range (IQR)] duration of follow-up for this cohort was 17 (10, 29) months. Fourteen children achieved remission, and none had recurrent strokes after the initiation of anti-TNF drugs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>DADA-2 closely resembles PAN; early age of onset and CNS stroke are striking differentiating features from classic PAN. Most children respond well to anti-TNF agents without serious adverse events being observed during short-term follow-up.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae489","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T22:30:53Z","timestamp":1726093853000},"page":"2179-2184","source":"Crossref","is-referenced-by-count":2,"title":["Clinical spectrum of and outcomes for Indian children with deficiency of adenosine deaminase 2 (DADA2): a multicentric study"],"prefix":"10.1093","volume":"64","author":[{"given":"Sathish","family":"Kumar","sequence":"first","affiliation":[{"name":"Division of Pediatric Rheumatology, Department of Pediatrics, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akagri","family":"Chugh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Rheymatology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha Cheryl","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, Department of Pediatrics, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Punnen","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, Department of Pediatrics, Christian Medical College , Vellore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-1337","authenticated-orcid":false,"given":"Chandrika","family":"Bhat","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology Services, Rainbow Children Hospital , Bangalore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0338-7517","authenticated-orcid":false,"given":"Pratap","family":"Patra","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences , Patna,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology Services, Department of Pediatrics, Jupiter Hospital , Thane,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Rheymatology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Hematology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amiya Ranjan","family":"Nayak","sequence":"additional","affiliation":[{"name":"Department of Hematology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Lingappa","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurosciences, Rainbow Children\u2019s Hospital , Bangalore,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Rheymatology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Rheymatology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Naranje","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Jana","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-0536","authenticated-orcid":false,"given":"Narendra Kumar","family":"Bagri","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Rheymatology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Rheymatology, All India Institute of Medical Sciences , New Delhi,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-2401","authenticated-orcid":false,"given":"Athimalaipet V","family":"Ramanan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Bristol Royal Hospital for Children , Bristol,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"2025040212110339800_keae489-B1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.semarthrit.2021.04.009","article-title":"Systematic review of childhood-onset polyarteritis nodosa and DADA2","volume":"51","author":"Kasap Cuceoglu","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025040212110339800_keae489-B2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"2025040212110339800_keae489-B3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med"},{"key":"2025040212110339800_keae489-B4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J Clin Immunol"},{"key":"2025040212110339800_keae489-B5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00281-022-00918-8","article-title":"Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)","volume":"44","author":"Lee","year":"2022","journal-title":"Semin Immunopathol"},{"key":"2025040212110339800_keae489-B6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/art.41500","article-title":"Deficiency of adenosine deaminase 2 (DADA2) in adults and children: experience from India","volume":"73","author":"Sharma","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025040212110339800_keae489-B7","first-page":"405","volume":"17","author":"Richards"},{"key":"2025040212110339800_keae489-B8","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMc1801927","article-title":"Treatment strategies for deficiency of adenosine deaminase 2","volume":"380","author":"Ombrello","year":"2019","journal-title":"N Engl J Med"},{"key":"2025040212110339800_keae489-B9","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1093\/rheumatology\/keaa837","article-title":"Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)","volume":"60","author":"Cooray","year":"2021","journal-title":"Rheumatology"},{"key":"2025040212110339800_keae489-B10","doi-asserted-by":"crossref","first-page":"e2315894","DOI":"10.1001\/jamanetworkopen.2023.15894","article-title":"Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025040212110339800_keae489-B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/BOR.0000000000000669","article-title":"A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2","volume":"32","author":"Sahin","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"2025040212110339800_keae489-B12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaci.2014.10.010","article-title":"Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency","volume":"135","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2025040212110339800_keae489-B13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","article-title":"Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations","volume":"55","year":"2016","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae489\/60591195\/keae489.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/2179\/60591195\/keae489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/2179\/60591195\/keae489.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T17:09:56Z","timestamp":1743613796000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/2179\/7755051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,9,11]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae489","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,9,11]]}}}